These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

530 related items for PubMed ID: 30864255

  • 1. The results of HLA-incompatible kidney transplantation according to pre-transplant crossmatch tests: Donor-specific antibody as a prominent predictor of acute rejection.
    Kwon H, Kim YH, Kim JY, Choi JY, Shin S, Jung JH, Park SK, Han DJ.
    Clin Transplant; 2019 May; 33(5):e13533. PubMed ID: 30864255
    [Abstract] [Full Text] [Related]

  • 2. Impact of alloantibody strength in crossmatch negative DSA positive kidney transplantation.
    Wu P, Jin J, Everly MJ, Lin C, Terasaki PI, Chen J.
    Clin Biochem; 2013 Oct; 46(15):1389-93. PubMed ID: 23726814
    [Abstract] [Full Text] [Related]

  • 3. Characteristics of donor-specific anti-HLA antibodies and outcome in renal transplant patients treated with a standardized induction regimen.
    Zecher D, Bach C, Staudner C, Böger CA, Bergler T, Banas B, Spriewald BM.
    Nephrol Dial Transplant; 2017 Apr 01; 32(4):730-737. PubMed ID: 28339671
    [Abstract] [Full Text] [Related]

  • 4. Impact of pretransplant donor-specific antibodies on kidney allograft recipients with negative flow cytometry cross-matches.
    Kwon H, Kim YH, Choi JY, Shin S, Jung JH, Park SK, Han DJ.
    Clin Transplant; 2018 Jun 01; 32(6):e13266. PubMed ID: 29676812
    [Abstract] [Full Text] [Related]

  • 5. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC, Ozawa M.
    Clin Transpl; 2007 Jun 01; ():219-26. PubMed ID: 18642453
    [Abstract] [Full Text] [Related]

  • 6. Preformed C1q-binding Donor-specific Anti-HLA Antibodies and Graft Function After Kidney Transplantation.
    Okabe Y, Noguchi H, Miyamoto K, Kaku K, Tsuchimoto A, Masutani K, Nakamura M.
    Transplant Proc; 2018 Dec 01; 50(10):3460-3466. PubMed ID: 30577221
    [Abstract] [Full Text] [Related]

  • 7. Clinical Significance of Pretransplant Donor-Specific Antibodies in the Setting of Negative Cell-Based Flow Cytometry Crossmatching in Kidney Transplant Recipients.
    Adebiyi OO, Gralla J, Klem P, Freed B, Davis S, Wiseman AC, Cooper JE.
    Am J Transplant; 2016 Dec 01; 16(12):3458-3467. PubMed ID: 27140940
    [Abstract] [Full Text] [Related]

  • 8. Relevance of different antibody detection methods for the prediction of antibody-mediated rejection and deceased-donor kidney allograft survival.
    Vlad G, Ho EK, Vasilescu ER, Colovai AI, Stokes MB, Markowitz GS, D'Agati VD, Cohen DJ, Ratner LE, Suciu-Foca N.
    Hum Immunol; 2009 Aug 01; 70(8):589-94. PubMed ID: 19375470
    [Abstract] [Full Text] [Related]

  • 9. Combined liver-kidney transplantation with positive crossmatch: Role of delayed kidney transplantation.
    Goggins WC, Ekser B, Rokop Z, Lutz AJ, Mihaylov P, Mangus RS, Fridell JA, Powelson JA, Kubal CA.
    Surgery; 2021 Oct 01; 170(4):1240-1247. PubMed ID: 34092375
    [Abstract] [Full Text] [Related]

  • 10. Characteristics of Circulating Donor Human Leukocyte Antigen-specific Immunoglobulin G Antibodies Predictive of Acute Antibody-mediated Rejection and Kidney Allograft Failure.
    Kannabhiran D, Lee J, Schwartz JE, Friedlander R, Aull M, Muthukumar T, Campbell S, Epstein D, Seshan SV, Kapur S, Sharma VK, Suthanthiran M, Dadhania D.
    Transplantation; 2015 Jun 01; 99(6):1156-64. PubMed ID: 25629531
    [Abstract] [Full Text] [Related]

  • 11. Analysis of Luminex-based Algorithms to Define Unacceptable HLA Antibodies in CDC-crossmatch Negative Kidney Transplant Recipients.
    Zecher D, Bach C, Preiss A, Staudner C, Utpatel K, Evert M, Jung B, Bergler T, Böger CA, Spriewald BM, Banas B.
    Transplantation; 2018 Jun 01; 102(6):969-977. PubMed ID: 29470350
    [Abstract] [Full Text] [Related]

  • 12. Epitope Analysis Aids in Transplant Decision Making by Determining the Clinical Relevance of Apparent Pre-Transplant Donor Specific Antibodies (DSA).
    Pandey S, Harville TO.
    Ann Clin Lab Sci; 2019 Jan 01; 49(1):50-56. PubMed ID: 30814077
    [Abstract] [Full Text] [Related]

  • 13. Analysis of preformed donor-specific anti-HLA antibodies characteristics for prediction of antibody-mediated rejection in kidney transplantation.
    Malheiro J, Tafulo S, Dias L, Martins LS, Fonseca I, Beirão I, Castro-Henriques A, Cabrita A.
    Transpl Immunol; 2015 Mar 01; 32(2):66-71. PubMed ID: 25661873
    [Abstract] [Full Text] [Related]

  • 14. Deceased donor kidney transplantation across donor-specific antibody barriers: predictors of antibody-mediated rejection.
    Schwaiger E, Eskandary F, Kozakowski N, Bond G, Kikić Ž, Yoo D, Rasoul-Rockenschaub S, Oberbauer R, Böhmig GA.
    Nephrol Dial Transplant; 2016 Aug 01; 31(8):1342-51. PubMed ID: 27190362
    [Abstract] [Full Text] [Related]

  • 15. Histological picture of antibody-mediated rejection without donor-specific anti-HLA antibodies: Clinical presentation and implications for outcome.
    Senev A, Coemans M, Lerut E, Van Sandt V, Daniëls L, Kuypers D, Sprangers B, Emonds MP, Naesens M.
    Am J Transplant; 2019 Mar 01; 19(3):763-780. PubMed ID: 30107078
    [Abstract] [Full Text] [Related]

  • 16. Frequent development of subclinical chronic antibody-mediated rejection within 1 year after renal transplantation with pre-transplant positive donor-specific antibodies and negative CDC crossmatches.
    Yamanaga S, Watarai Y, Yamamoto T, Tsujita M, Hiramitsu T, Nanmoku K, Goto N, Takeda A, Morozumi K, Katayama A, Saji H, Uchida K, Kobayashi T.
    Hum Immunol; 2013 Sep 01; 74(9):1111-8. PubMed ID: 23792054
    [Abstract] [Full Text] [Related]

  • 17. Human leukocyte antigen antibody-incompatible renal transplantation: excellent medium-term outcomes with negative cytotoxic crossmatch.
    Higgins R, Lowe D, Hathaway M, Williams C, Lam FT, Kashi H, Tan LC, Imray C, Fletcher S, Chen K, Krishnan N, Hamer R, Daga S, Edey M, Zehnder D, Briggs D.
    Transplantation; 2011 Oct 27; 92(8):900-6. PubMed ID: 21968524
    [Abstract] [Full Text] [Related]

  • 18. Clinical significance of low pre-transplant donor specific antibodies (DSA) in living donor kidney recipients with negative complement-dependent cytotoxicity crossmatches (CDCXM), and negative flow cytometry crossmatches (FLXM) - A single-center experience.
    Olszowska-Zaremba N, Gozdowska J, Zagożdżon R.
    Transpl Immunol; 2022 Oct 27; 74():101672. PubMed ID: 35868613
    [Abstract] [Full Text] [Related]

  • 19. Correlation of Luminex-Based Single Antigen Based Results With Complement-Dependent Cytotoxicity Crossmatch and Flow Cytometry Crossmatch Results: A Single-Center Experience From Istanbul.
    Oguz SR, Sinangil A, Barlas S, Ciftci HS, Ulusoy E, İzgi DK, Ogret Y, Ecder T, Akin B.
    Transplant Proc; 2023 Mar 27; 55(2):303-308. PubMed ID: 36890054
    [Abstract] [Full Text] [Related]

  • 20. The Impact of Donor-Specific Anti-Human Leukocyte Antigen (HLA) Antibody Rebound on the Risk of Antibody Mediated Rejection in Sensitized Kidney Transplant Recipients.
    Lee KW, Park JB, Cho CW, Lee N, Yoo H, Kim K, Park H, Kang ES, Huh W, Kim S.
    Ann Transplant; 2017 Mar 28; 22():166-176. PubMed ID: 28348361
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.